logo
Log inSign Up. It's Free
    Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
    ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
    Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
    Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
    Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
    For ProvidersRequest DemoJoin Research Panel
    For BusinessHCP ActivationSamplesWeb AppsHub ServicesAI ProductsContact Sales
    Tools & MorePrescribing InfoCoverageSavingsPrescriber AICompare Drugs
    CompanyAboutInsightsCareersContact
    Legit Script Certified
    Get the latest insights in your inbox
    Follow us
    Legit Script Certified
    • Terms and Conditions
    • Privacy Policy
    • © 2025 PrescriberPoint. All Rights Reserved.

    Drugs interactions for

    • 1 Major drug interactions (including ingredients like Latanoprost)
    • 15 Moderate drug interactions (including ingredients like Bendroflumethiazide, Cenobamate, Chlorothiazide)
    • 122 Minor drug interactions (including ingredients like Acebutolol, Aceclofenac, Acetylsalicylic acid)
    138 interactions for
    A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and .
    Latanoprost
    The risk or severity of intraocular pressure can be increased when Latanoprost is combined with Bimatoprost.
    Bendroflumethiazide
    The therapeutic efficacy of Bimatoprost can be increased when used in combination with Bendroflumethiazide.
    Cenobamate
    The serum concentration of Bimatoprost can be decreased when it is combined with Cenobamate.
    Chlorothiazide
    The therapeutic efficacy of Bimatoprost can be increased when used in combination with Chlorothiazide.
    Hydrochlorothiazide
    The therapeutic efficacy of Bimatoprost can be increased when used in combination with Hydrochlorothiazide.
    Hydroflumethiazide
    The therapeutic efficacy of Bimatoprost can be increased when used in combination with Hydroflumethiazide.
    Indapamide
    The therapeutic efficacy of Indapamide can be increased when used in combination with Bimatoprost.
    Latanoprostene bunod
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Latanoprostene bunod.
    Polythiazide
    The therapeutic efficacy of Bimatoprost can be increased when used in combination with Polythiazide.
    Quetiapine
    Quetiapine may increase the hypotensive activities of Bimatoprost.
    Ritlecitinib
    The serum concentration of Bimatoprost can be increased when it is combined with Ritlecitinib.
    Serdexmethylphenidate
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Serdexmethylphenidate.
    Sodium ferric gluconate complex
    The risk or severity of hypotension can be increased when Sodium ferric gluconate complex is combined with Bimatoprost.
    Tafluprost
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tafluprost.
    Tenofovir alafenamide
    The serum concentration of Tenofovir alafenamide can be increased when it is combined with Bimatoprost.
    Travoprost
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Travoprost.
    Acebutolol
    Bimatoprost may increase the hypotensive activities of Acebutolol.
    Aceclofenac
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Aceclofenac.
    Acetylsalicylic acid
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.
    Aliskiren
    Bimatoprost may increase the hypotensive activities of Aliskiren.
    Ambrisentan
    Bimatoprost may increase the hypotensive activities of Ambrisentan.
    Amlodipine
    Amlodipine may increase the hypotensive activities of Bimatoprost.
    Antipyrine
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Antipyrine.
    Aprocitentan
    Bimatoprost may increase the hypotensive activities of Aprocitentan.
    Atenolol
    Atenolol may increase the hypotensive activities of Bimatoprost.
    Avanafil
    Bimatoprost may increase the hypotensive activities of Avanafil.
    Azilsartan medoxomil
    Bimatoprost may increase the hypotensive activities of Azilsartan medoxomil.
    Balsalazide
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Balsalazide.
    Benazepril
    Benazepril may increase the hypotensive activities of Bimatoprost.
    Betaxolol
    Betaxolol may increase the hypotensive activities of Bimatoprost.
    Bisoprolol
    Bisoprolol may increase the hypotensive activities of Bimatoprost.
    Bosentan
    Bosentan may increase the hypotensive activities of Bimatoprost.
    Bretylium
    Bimatoprost may increase the hypotensive activities of Bretylium.
    Candesartan cilexetil
    Candesartan cilexetil may increase the hypotensive activities of Bimatoprost.
    Captopril
    Bimatoprost may increase the hypotensive activities of Captopril.
    Carteolol
    Carteolol may increase the hypotensive activities of Bimatoprost.
    Carvedilol
    Bimatoprost may increase the hypotensive activities of Carvedilol.
    Celecoxib
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Celecoxib.
    Chlorthalidone
    Chlorthalidone may increase the hypotensive activities of Bimatoprost.
    Clonidine
    Clonidine may increase the hypotensive activities of Bimatoprost.
    Dasiglucagon
    Bimatoprost may increase the hypotensive activities of Dasiglucagon.
    Diazoxide
    Bimatoprost may increase the hypotensive activities of Diazoxide.
    Diclofenac
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diclofenac.
    Diflunisal
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diflunisal.
    Diltiazem
    Diltiazem may increase the hypotensive activities of Bimatoprost.
    Dorzolamide
    Dorzolamide may increase the hypotensive activities of Bimatoprost.
    Doxazosin
    Doxazosin may increase the hypotensive activities of Bimatoprost.
    Enalapril
    Enalapril may increase the hypotensive activities of Bimatoprost.
    Enalaprilat
    Bimatoprost may increase the hypotensive activities of Enalaprilat.
    Eplerenone
    Eplerenone may increase the hypotensive activities of Bimatoprost.
    Epoprostenol
    Bimatoprost may increase the hypotensive activities of Epoprostenol.
    Eprosartan
    Eprosartan may increase the hypotensive activities of Bimatoprost.
    Esmolol
    Esmolol may increase the hypotensive activities of Bimatoprost.
    Ethenzamide
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ethenzamide.
    Etodolac
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etodolac.
    Felodipine
    Bimatoprost may increase the hypotensive activities of Felodipine.
    Fenoldopam
    Fenoldopam may increase the hypotensive activities of Bimatoprost.
    Fenoprofen
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Fenoprofen.
    Flurbiprofen
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Flurbiprofen.
    Fosinopril
    Fosinopril may increase the hypotensive activities of Bimatoprost.
    Furosemide
    Furosemide may increase the hypotensive activities of Bimatoprost.
    Glycol salicylate
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Glycol salicylate.
    Guanfacine
    Bimatoprost may increase the hypotensive activities of Guanfacine.
    Hydralazine
    Bimatoprost may increase the hypotensive activities of Hydralazine.
    Ibuprofen
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ibuprofen.
    Icosapent
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Icosapent.
    Iloprost
    Iloprost may increase the hypotensive activities of Bimatoprost.
    Indomethacin
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Indomethacin.
    Irbesartan
    Bimatoprost may increase the hypotensive activities of Irbesartan.
    Isradipine
    Isradipine may increase the hypotensive activities of Bimatoprost.
    Ketoprofen
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketoprofen.
    Ketorolac
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketorolac.
    Labetalol
    Labetalol may increase the hypotensive activities of Bimatoprost.
    Landiolol
    Bimatoprost may increase the hypotensive activities of Landiolol.
    Levamlodipine
    Bimatoprost may increase the hypotensive activities of Levamlodipine.
    Lisinopril
    Lisinopril may increase the hypotensive activities of Bimatoprost.
    Lofexidine
    Bimatoprost may increase the hypotensive activities of Lofexidine.
    Losartan
    Losartan may increase the hypotensive activities of Bimatoprost.
    Macitentan
    Bimatoprost may increase the hypotensive activities of Macitentan.
    Magnesium salicylate
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Magnesium salicylate.
    Mecamylamine
    Mecamylamine may increase the hypotensive activities of Bimatoprost.
    Meclofenamic acid
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meclofenamic acid.
    Mefenamic acid
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mefenamic acid.
    Meloxicam
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meloxicam.
    Menthyl salicylate
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Menthyl salicylate.
    Methyldopa
    Bimatoprost may increase the hypotensive activities of Methyldopa.
    Metolazone
    Metolazone may increase the hypotensive activities of Bimatoprost.
    Metoprolol
    Metoprolol may increase the hypotensive activities of Bimatoprost.
    Metyrosine
    Metyrosine may increase the hypotensive activities of Bimatoprost.
    Minoxidil
    Minoxidil may increase the hypotensive activities of Bimatoprost.
    Moexipril
    Moexipril may increase the hypotensive activities of Bimatoprost.
    Nabumetone
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nabumetone.
    Nadolol
    Bimatoprost may increase the hypotensive activities of Nadolol.
    Naproxen
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Naproxen.
    Nebivolol
    Bimatoprost may increase the hypotensive activities of Nebivolol.
    Nicardipine
    Nicardipine may increase the hypotensive activities of Bimatoprost.
    Nimodipine
    Nimodipine may increase the hypotensive activities of Bimatoprost.
    Nisoldipine
    Nisoldipine may increase the hypotensive activities of Bimatoprost.
    Nitroglycerin
    Nitroglycerin may increase the hypotensive activities of Bimatoprost.
    Nitroprusside
    Nitroprusside may increase the hypotensive activities of Bimatoprost.
    Olmesartan
    Olmesartan may increase the hypotensive activities of Bimatoprost.
    Oxaprozin
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxaprozin.
    Parecoxib
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Parecoxib.
    Perindopril
    Perindopril may increase the hypotensive activities of Bimatoprost.
    Phenoxybenzamine
    Bimatoprost may increase the hypotensive activities of Phenoxybenzamine.
    Phentolamine
    Phentolamine may increase the hypotensive activities of Bimatoprost.
    Pindolol
    Bimatoprost may increase the hypotensive activities of Pindolol.
    Piroxicam
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Piroxicam.
    Prazosin
    Prazosin may increase the hypotensive activities of Bimatoprost.
    Propranolol
    Propranolol may increase the hypotensive activities of Bimatoprost.
    Propyphenazone
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Propyphenazone.
    Quinapril
    Quinapril may increase the hypotensive activities of Bimatoprost.
    Quinine
    Quinine may increase the hypotensive activities of Bimatoprost.
    Ramipril
    Ramipril may increase the hypotensive activities of Bimatoprost.
    Reserpine
    Reserpine may increase the hypotensive activities of Bimatoprost.
    Riociguat
    Bimatoprost may increase the hypotensive activities of Riociguat.
    Salicylamide
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylamide.
    Salicylic acid
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylic acid.
    Salsalate
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salsalate.
    Salvia miltiorrhiza root
    Salvia miltiorrhiza root may increase the hypotensive activities of Bimatoprost.
    Selexipag
    Bimatoprost may increase the hypotensive activities of Selexipag.
    Silodosin
    The risk or severity of orthostatic hypotension and dizziness can be increased when Bimatoprost is combined with Silodosin.
    Sotatercept
    Bimatoprost may increase the hypotensive activities of Sotatercept.
    Spironolactone
    Spironolactone may increase the hypotensive activities of Bimatoprost.
    Sulfasalazine
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Sulfasalazine.
    Sulindac
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Sulindac.
    Tadalafil
    Tadalafil may increase the hypotensive activities of Bimatoprost.
    Telmisartan
    Bimatoprost may increase the hypotensive activities of Telmisartan.
    Terazosin
    Bimatoprost may increase the hypotensive activities of Terazosin.
    Timolol
    Timolol may increase the hypotensive activities of Bimatoprost.
    Tocopherylquinone
    Bimatoprost may increase the hypotensive activities of Tocopherylquinone.
    Tolmetin
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tolmetin.
    Torasemide
    Torasemide may increase the hypotensive activities of Bimatoprost.
    Trandolapril
    Trandolapril may increase the hypotensive activities of Bimatoprost.
    Treprostinil
    Treprostinil may increase the hypotensive activities of Bimatoprost.
    Valdecoxib
    The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Valdecoxib.
    Valsartan
    Valsartan may increase the hypotensive activities of Bimatoprost.
    Ziprasidone
    Ziprasidone may increase the antihypertensive activities of Bimatoprost.
    Coverage Restrictions for Get your patient on